Community and Social Context: An Important Social Determinant of Cardiovascular Disease

Methodist Debakey Cardiovasc J. 2021 Sep 24;17(4):15-27. doi: 10.14797/mdcvj.846. eCollection 2021.

Abstract

Disease prevention frameworks and clinical practice guidelines in the United States (US) have traditionally ignored upstream social determinants of health (SDOH), which are critical for reducing disparities in cardiovascular disease (CVD)-the leading cause of death in the US. Existing evidence demonstrates a protective effect of social support, social cohesion, and community engagement on overall health and wellbeing. Increasing community and social support is a major objective of the Healthy People 2030 initiative, with special provisions for vulnerable populations. However, to date, existing evidence of the association between community and social context (CSC)-an integral SDOH domain-and CVD has not been reviewed extensively. In particular, the individual and cumulative impact of CSC on CVD risk and the pathways linking CSC to cardiovascular outcomes are not well understood. In this review, we critically appraise current knowledge of the association between CSC and CVD, describe potential pathways linking CSC to CVD, and identify opportunities for evidence-based policy and practice interventions to improve CVD outcomes.

Keywords: cardiovascular disease; community; social context; social determinants of health.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / therapy
  • Delivery of Health Care
  • Humans
  • Social Determinants of Health*
  • United States / epidemiology
  • Vulnerable Populations

Grants and funding

Dr. Nasir is on the advisory board of Amgen, Novartis Medicine Company, and his research is partly supported by the Jerold B. Katz Academy of Translational Research.